Gonadotropin-releasing Hormone Agonist (GnRHa) Plus Letrozole In Young Women With Early Endometrial Cancer

This study is testing a hormone-based treatment combination for young women with very early-stage uterine (endometrial) cancer who want to preserve their ability to have children. Instead of surgery to remove the uterus, participants receive a combination of hormonal medications to see if the cancer can be controlled without losing fertility. **You may be eligible if...** - You have early-stage endometrial cancer (grade 1, endometrioid type, no spread into the uterine wall) confirmed by biopsy - Imaging scans show no signs of the cancer spreading beyond the uterus - You strongly wish to preserve your fertility or uterus - You are able to attend regular follow-up appointments at the study hospital **You may NOT be eligible if...** - Your cancer has grown into the uterine wall or spread outside the uterus - Your cancer has returned after prior treatment - You have serious liver or kidney disease - You have another type of uterine or reproductive cancer, breast cancer, or a hormone-sensitive tumor - Your doctor recommends hysterectomy or a non-hormonal treatment approach Talk to your doctor to see if this trial is right for you.